Amyotrophic Lateral Sclerosis News -- ScienceDaily
Mar 13, 2024 — Latest research news on amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, including experimental treatments.
What is ALS? Experts explain symptoms to look out for ... - CBS News
Aug 9, 2023 — ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, making the brain unable to control muscle movement. As the illness …
Amyotrophic lateral sclerosis - Latest research and news - Nature
Nov 16, 2024 — Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in …
Scientists may have discovered a potential cure for ALS
May 17, 2024 — A team of researchers at Western University have made a major breakthrough that could pave the way to a cure for amyotrophic lateral sclerosis (ALS) — a devastating …
National Academies Releases Road Map for Turning ALS from …
June 18, 2024 (Arlington, VA) – The ALS Association commends the National Academies for its groundbreaking new report on amyotrophic lateral sclerosis (ALS). The report, the result of an …
New Treatment Strategy Offers Hope for Halting ALS Progression
Jan 30, 2024 — A major breakthrough in the treatment of amyotrophic lateral sclerosis, known as ALS, can potentially help stop the disease in its tracks in as much as half of the cases in the …
New therapeutic strategy to reduce neuronal death in amyotrophic ...
Nov 16, 2023 — Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects neurons in the brain and spinal cord causing loss of muscle control. Scientists have now …
Amyotrophic lateral sclerosis - News and Latest Updates - Medical Xpress
Oct 31, 2024 — Using sequencing techniques, researchers associated 51 mutations in mitochondrial DNA with amyotrophic lateral sclerosis (ALS), an incurable degenerative …
Amyotrophic lateral sclerosis (ALS) - MIT News
May 2, 2024 — Single-cell gene expression patterns in the brain, and evidence from follow-up experiments, reveal many shared cellular and molecular similarities that could be targeted for …
Epigenomic analysis sheds light on risk factors for ALS
May 2, 2024 — In a study of cells from nearly 400 amyotrophic lateral sclerosis (ALS) patients, MIT researchers identified genomic regions with chemical modifications linked to disease progression.
- Some results have been removed